Clinical trials sponsored by Hadassah Medical Organization
7
Recruiting trials
15
Conditions studied
Phase breakdown
Phase 1 3Phase 2 3Phase 4 1Not applicable 3
Conditions studied
Recruiting trials led by Hadassah Medical Organization
- A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases
- Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
- Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
- Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
- Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases
- Modified Vaccine for High Risk or Low Residual Melanoma Patients
- Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals
Common questions
How many trials is Hadassah Medical Organization recruiting for?
Hadassah Medical Organization is the lead sponsor of 7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.